• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方药覆盖范围与老年人:2003年全国调查结果

Prescription drug coverage and seniors: findings from a 2003 national survey.

作者信息

Safran Dana Gelb, Neuman Patricia, Schoen Cathy, Kitchman Michelle S, Wilson Ira B, Cooper Barbara, Li Angela, Chang Hong, Rogers William H

机构信息

Health Institute at Tufts-New England Medical Center, Boston, USA.

出版信息

Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-152-W5-166. doi: 10.1377/hlthaff.w5.152.

DOI:10.1377/hlthaff.w5.152
PMID:15840625
Abstract

Beginning in 2006 the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) will offer pharmacy benefits to forty-two million Medicare beneficiaries nationwide. In a 2003 national survey of Medicare beneficiaries age sixty-five and older, more than one-quarter reported no prescription coverage, and nearly half of low-income seniors in some states lacked coverage. Wide coverage differences among states highlight implementation challenges and the need for tailored enrollment strategies. Evidence of Medicaid's highly effective coverage delineates the importance of assuring this group's continued protection under Part D plans. Reports of complex drug regimens, multiple prescribing physicians and pharmacies, nonadherence, and reimportation demonstrate the challenges of integrating seniors' prescription care. We discuss MMA's potential to improve quality and the need to monitor performance.

摘要

从2006年开始,《医疗保险处方药、改进与现代化法案》(MMA)将为全国4200万医疗保险受益人提供药房福利。在2003年对65岁及以上医疗保险受益人的全国性调查中,超过四分之一的人表示没有处方药保险,在一些州,近一半的低收入老年人缺乏保险。各州之间广泛的保险差异凸显了实施方面的挑战以及制定针对性参保策略的必要性。医疗补助计划(Medicaid)高效保险的证据表明,确保该群体在D部分计划下持续得到保护非常重要。关于复杂药物治疗方案、多位开处方医生和药房、不依从以及药品再进口的报告表明,整合老年人的处方护理存在挑战。我们讨论了MMA在提高质量方面的潜力以及监测绩效的必要性。

相似文献

1
Prescription drug coverage and seniors: findings from a 2003 national survey.处方药覆盖范围与老年人:2003年全国调查结果
Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-152-W5-166. doi: 10.1377/hlthaff.w5.152.
2
Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.药品:《医疗保险现代化法案》——2005年。年终问题简报。
Issue Brief Health Policy Track Serv. 2005 Dec 31:1-21.
3
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
4
Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.医疗保险处方药福利进展报告:2006年全国老年人调查结果
Health Aff (Millwood). 2007 Sep-Oct;26(5):w630-43. doi: 10.1377/hlthaff.26.5.w630. Epub 2007 Aug 21.
5
Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.医疗保险D部分:成就与持续挑战。医疗保险D部分对马萨诸塞州医疗项目及受益人的影响。
Issue Brief (Mass Health Policy Forum). 2007 May 30(32):1-32.
6
Defining a future for fee-for-service Medicare.为按服务收费的医疗保险界定未来。
Health Aff (Millwood). 2006 May-Jun;25(3):864-8. doi: 10.1377/hlthaff.25.3.864.
7
Changes in drug utilization for seniors without prior prescription drug insurance.无既往处方药保险的老年人的药物使用变化。
Find Brief. 2009 Mar;12(2):1-3.
8
2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.2007年北卡罗来纳州感染艾滋病毒/艾滋病的人通过联邦医疗保险D部分获得抗逆转录病毒药物的成本及覆盖情况。
N C Med J. 2008 Jan-Feb;69(1):6-13.
9
Medicare advantage: déjà vu all over again?医疗保险优势:似曾相识?
Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-586-97. doi: 10.1377/hlthaff.w4.586.
10
Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.医疗保险D部分对农村独立药房的持续影响,这些药房是其所在社区唯一的零售提供者。
Res Social Adm Pharm. 2009 Mar;5(1):17-30. doi: 10.1016/j.sapharm.2008.04.004. Epub 2009 Jan 21.

引用本文的文献

1
Prevalence of polypharmacy and medication-related quality of life among adult patients in Al-Ahsa, Saudi Arabia.沙特阿拉伯阿哈萨的成年患者中多药治疗的流行情况和与药物相关的生活质量。
J Med Life. 2023 Sep;16(9):1415-1420. doi: 10.25122/jml-2023-0101.
2
Relationship between Treatment Burden, Health Literacy, and Medication Adherence in Older Adults Coping with Multiple Chronic Conditions.老年人多重慢性病应对中的治疗负担、健康素养与药物依从性的关系。
Medicina (Kaunas). 2023 Jul 31;59(8):1401. doi: 10.3390/medicina59081401.
3
Multimorbidity and out-of-pocket expenditure on medicine in Europe: Longitudinal analysis of 13 European countries between 2013 and 2015.
欧洲的多种疾病共存和药品自付支出:2013 年至 2015 年 13 个欧洲国家的纵向分析。
Front Public Health. 2023 Jan 5;10:1053515. doi: 10.3389/fpubh.2022.1053515. eCollection 2022.
4
Polypharmacy in Older Adults with Alzheimer's Disease.老年阿尔茨海默病患者的多种药物治疗。
Medicina (Kaunas). 2022 Oct 13;58(10):1445. doi: 10.3390/medicina58101445.
5
Medication cost-reducing behaviors in older adults with atrial fibrillation: The SAGE-AF study.老年心房颤动患者的药物费用降低行为:SAGE-AF 研究。
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):125-134. doi: 10.1016/j.japh.2022.08.030. Epub 2022 Sep 8.
6
Home Medication Regimens Increase in Complexity After Admission for Fall in the Older Trauma Patient.老年创伤患者跌倒入院后,居家用药方案的复杂性增加。
Am Surg. 2023 Nov;89(11):4438-4444. doi: 10.1177/00031348221083958. Epub 2022 Jul 16.
7
Social capital and cost-related medication nonadherence (CRN): A retrospective longitudinal cohort study using the Health and Retirement Study data, 2006-2016.社会资本与药物费用相关的治疗依从性差(CRN):一项使用2006 - 2016年健康与退休研究数据的回顾性纵向队列研究。
SSM Popul Health. 2020 Oct 5;12:100671. doi: 10.1016/j.ssmph.2020.100671. eCollection 2020 Dec.
8
Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).基线患病率:患有高血压且痴呆风险升高的老年患者中的药物滥用:来自阿尔茨海默病风险降低研究(rrAD)的结果。
J Alzheimers Dis. 2020;77(1):175-182. doi: 10.3233/JAD-200122.
9
Unfilled Prescriptions of Medicare Beneficiaries: Prevalence, Reasons, and Types of Medicines Prescribed.医疗保险受益人的未用处方:流行率、原因和所开药物类型。
J Manag Care Spec Pharm. 2020 Aug;26(8):935-942. doi: 10.18553/jmcp.2020.26.8.935.
10
How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D.增加阿片类药物的医疗可及性如何导致阿片类药物流行:来自医疗保险处方药部分的证据。
J Health Econ. 2020 May;71:102286. doi: 10.1016/j.jhealeco.2019.102286. Epub 2020 Mar 4.